AI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.

Edison Scientific and investment firm Population Health Partners are teaming up to leverage AI agents in drug discovery and development.

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, those doing research at pharma companies.

Anthropic is targeting the science vertical with a new AI workbench.

AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of artificial intelligence. Can it make drugs too?

AI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.

The AI drug boom has a long way to go before reaching patients.